Literature DB >> 24583703

Usefulness of intraoperative continuous infusion of tranexamic acid during emergency surgery for type A acute aortic dissection.

Kun Tae Ahn1, Kazuo Yamanaka, Atsushi Iwakura, Keiichi Hirose, Daisuke Nakatsuka, Takayoshi Kusuhara, Jin Ikarashi.   

Abstract

PURPOSE: We investigated the influence of intraoperative continuous tranexamic acid (TA) infusion on the amount of blood transfusion required in emergency surgery for type A acute aortic dissection.
METHODS: The study was based on the data of 55 consecutive patients who underwent surgery for type A acute aortic dissection. The patients were divided into 2 groups for comparison: Group T, consisting of 26 patients who received intraoperative continuous infusion of TA, and Group N, consisting of 29 patients who did not receive TA infusion during the surgery.
RESULTS: The mean amounts of blood transfusion required during and after surgery were compared between the 2 groups: they were 10.5 ± 8.7 and 16.2 ± 10.0 units of mannitol-adenine-phosphate-added red cell concentrate, 9.3 ± 8.6 and 17.1 ± 10.0 units of fresh frozen plasma, and 20.4 ± 12.2 and 29.7 ± 14.9 units of platelet concentrate, respectively, in Groups T and N. Thus, the amount of each of these blood products required was significantly reduced in Group T.
CONCLUSIONS: During emergency surgery for type A acute aortic dissection, continuous infusion of TA resulted in a significant reduction in the amount of blood transfusion required.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24583703      PMCID: PMC4989989          DOI: 10.5761/atcs.oa.13-00339

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  19 in total

1.  The risk associated with aprotinin in cardiac surgery.

Authors:  Dennis T Mangano; Iulia C Tudor; Cynthia Dietzel
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

2.  A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

Authors:  Dean A Fergusson; Paul C Hébert; C David Mazer; Stephen Fremes; Charles MacAdams; John M Murkin; Kevin Teoh; Peter C Duke; Ramiro Arellano; Morris A Blajchman; Jean S Bussières; Dany Côté; Jacek Karski; Raymond Martineau; James A Robblee; Marc Rodger; George Wells; Jennifer Clinch; Roanda Pretorius
Journal:  N Engl J Med       Date:  2008-05-14       Impact factor: 91.245

3.  Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.

Authors:  M Levi; M E Cromheecke; E de Jonge; M H Prins; B J de Mol; E Briët; H R Büller
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

4.  Effect of aprotinin on need for blood transfusion after repeat open-heart surgery.

Authors:  D Royston; B P Bidstrup; K M Taylor; R N Sapsford
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321

Review 5.  Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery.

Authors:  Robert J Porte; Frank W G Leebeek
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

7.  Aprotinin and tranexamic acid for high transfusion risk cardiac surgery.

Authors:  B I Wong; R F McLean; S E Fremes; K A Deemar; E M Harrington; G T Christakis; B S Goldman
Journal:  Ann Thorac Surg       Date:  2000-03       Impact factor: 4.330

8.  Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator.

Authors:  J Stibbe; C Kluft; E J Brommer; M Gomes; D S de Jong; J Nauta
Journal:  Eur J Clin Invest       Date:  1984-10       Impact factor: 4.686

9.  Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis.

Authors:  J J Munoz; N J Birkmeyer; J D Birkmeyer; G T O'Connor; L J Dacey
Journal:  Circulation       Date:  1999 Jan 5-12       Impact factor: 29.690

10.  Pharmacokinetics of tranexamic acid during cardiopulmonary bypass.

Authors:  Noreen P Dowd; Jacek M Karski; Davy C Cheng; Jo A Carroll; Yonggu Lin; Robert L James; John Butterworth
Journal:  Anesthesiology       Date:  2002-08       Impact factor: 7.892

View more
  2 in total

1.  Effect of massive blood transfusion on late outcomes after surgical repair of acute type A aortic dissection.

Authors:  Fang-Ting Chen; An-Hsun Chou; Victor Chien-Chia Wu; Chia-Hung Yang; Pao-Hsien Chu; Pei-Chi Ting; Shao-Wei Chen
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

2.  High-Dose Tranexamic Acid in Patients Underwent Surgical Repair of Aortic Dissection Might Reduce Postoperative Blood Loss: A Cohort Analysis.

Authors:  Jingfei Guo; Liang Cao; Hongbai Wang; Guangyu Liu; Yong Zhou; Lijing Yang; Yuan Jia; Su Yuan
Journal:  Front Surg       Date:  2022-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.